JIANGSU BIODA LIFE SCIENCE Co., LTD. was established in 2015, and currently has two production and R&D bases in Shanghai and Nantong, with more than 200 employees. At the beginning of 2022, BIODA Life science Park in Nantong North High-tech City, covering an area of 25,000 square meters, started construction. The first phase of the 15,000-square-meter vascular graft production plant was put into operation in December 2022. The company has set up an R&D center in Shanghai Zhangjiang Medical Valley, which has been stationed in October 2022. R&D center laboratory covers an area of 6,500 square meters, which can meet the development and production of a variety of products.
Since its establishment, BIODA and its subsidiaries have won the innovation fund support of Shanghai “Science and technology Innovation Action Plan” and the Outstanding Enterprise Award of “Enterpreneurship in Shanghai” International Innovation and Entrepreneurship Competition for many times. It was awarded into the “high-tech Enterprise Cultivation Pool” of Jiangsu Province, and won the title of “National high-tech Enterprise”.
VASOLINE®️ vascular graft was approved by NMPA on November 6, 2022 (NMPA 20223131515); Dialysis vascular prosthesis is currently in the clinical trial stage, and the product has been praised by doctors for its high quality. In China, VASOLINEE®️ ️vascular graft is the first and only one approve vascular graft brand.
At present, the company has more than 20 research projects, covering cardiovascular surgery, vascular surgery, cardiac surgery, general surgery and other departments. Relying on the technology platform of polymer materials, biological materials and metal scaffold molding, BIODA is constantly introducing more high-quality products for clinical needs to benefit the majority of patients.
Clear focus on goals, Wolf strong execution
Low-key, humble and pragmatic, and constantly surpass themselves
Meet and exceed customer needs, Provide safe and effective products
Meet the legal and regulatory requirements, Integrate quality into our products
Maintain the effectiveness and continuous improvement of the quality management system, Everyone`s responsibility./p>
公司在江苏启东成立。
全资子公司：上海百赫亚医疗科技有限公司成立。
百赫亚医疗科技是一家医疗技术研发及医疗器械制造服务商，公司专注于从事医疗科技、生物科技领域内的技术开发，主要为用户提供先关的技术咨询、自有技术成果转让等服务。
全资子公司：上海畅迪医疗科技有限公司成立。
经营范围包括许可项目：第二类医疗器械生产；第三类医疗器械生产；第三类医疗器械经营。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；化工产品销售（不含许可类化工产品）；机械设备销售；金属材料销售；塑料制品销售；信息技术咨询服务；货物进出口；技术进出口；第一类医疗器械生产；第一类医疗器械销售；第二类医疗器械销售。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）获南通政府批准25000平米工业用地用于生产。
公司在江苏启东成立。
全资子公司：上海百赫亚医疗科技有限公司成立。
百赫亚医疗科技是一家医疗技术研发及医疗器械制造服务商，公司专注于从事医疗科技、生物科技领域内的技术开发，主要为用户提供先关的技术咨询、自有技术成果转让等服务。
全资子公司：上海畅迪医疗科技有限公司成立。
经营范围包括许可项目：第二类医疗器械生产；第三类医疗器械生产；第三类医疗器械经营。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；化工产品销售（不含许可类化工产品）；机械设备销售；金属材料销售；塑料制品销售；信息技术咨询服务；货物进出口；技术进出口；第一类医疗器械生产；第一类医疗器械销售；第二类医疗器械销售。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）获南通政府批准25000平米工业用地用于生产。
